Agents

Tests

Reference

Tamoxifen, Toremifene, Fulvestrant, Letrozole, Anastrozole, Exemestane, Megestrol Acetate, Leuprolide, and Goserelin

ER

[35] - [43]

PR

[35] - [41] [44] [45]

Fluorouracil, Capecitabine, and Pemetrexed

TS

[46] - [48]

Paclitaxel, Docetaxel, and Nab-Paclitaxel

PGP

[49] [50]

SPARC Monoclonal

[51] [52]

SPARC Polyclonal

[51] [52]

TUBB 3

[53] - [56]

TLE3

[57]

Gemcitabine

RRM1

[58]

Irinotecan

TOPO1

[59] - [61]

Everolimus and Temsirolimus

ER

[62] - [64]

Her2/Neu

[61] [63] - [65]

PIK3CA

[66] - [68]

Imatinib

c-KIT

[69] [70]

PDGFRA

[71] - [73]

Vandetanib

RET

[74]

Doxorubicin, Liposomal-Doxorubicin, and Epirubicin

Her2/Neu

[75] [76]

PGP

[77] [78]

TOP2A

[79] [80]

Erlotinib and Gefitibib

PTEN

[81]

Trastuzumab, Pertuzumab, and Ado-trastuzumab Emtansine (T-DM1)

Her2/Neu

[62] [82] - [87]

Lapatinib

Her2/Neu

[88] - [90]

Temozolomide and dacarbazine

MGMT

[91] [92]

Docetaxel and Paclitaxel

PGP

[49] [50]

TLE3

[57]

TUBB 3

[53] - [56]